Zephyrx to Integrate Niox FeNO
Zephyrx will integrate FeNO by Niox into the Zephyrx Respiratory Cloud Platform to advance clinical research, according to a joint press release.
Tag: NIOX Vero FeNO
Zephyrx to Integrate Niox FeNO
Zephyrx will integrate FeNO by Niox into the Zephyrx Respiratory Cloud Platform to advance clinical research, according to a joint press release.
Read More
Vitalograph to Market NIOX FeNO Device
Vitalograph is now an authorized distributor of NIOX point-of-care fractional exhaled nitric oxide (FeNO) testing devices in the United States.
Read More
Circassia Expanding FeNO Asthma Testing into Primary Care
Asthma FeNO testing will be available in more US primary care settings as the result of a new national distribution model for Circassia Inc’s NIOX Vero FeNO testing device.
Read More
Niox Vero FeNO Device Now Available through Vizient Inc
Circassia Pharmaceuticals Inc has received a multiyear Innovative Technology contract for its Niox Vero asthma management products from Vizient Inc.
Read More
FeNO Testing: A New Biomarker for Inflammation Enhances Asthma Diagnosis and Management
Point-of-care FeNO testing is easy and fast, and adds a reliable and objective measure to the clinical evaluation of airway inflammation.
Read More